Browse studies

Find your next paid study

1,512 recruiting studies matching your filters

MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis

This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 positron emission tomography \[PET\]/magnetic resonance imaging \[MRI\]) for identifyi…

Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06389786

Observational

Amnioinfusion for Fetal Renal Failure

The goal of this clinical trial is to learn if serial amnioinfusions can improve the chances of survival for fetuses with severe kidney problems that cause low…

Multicystic Dysplastic KidneyPolycystic Kidney DiseaseFetal Renal Anomaly+6 more

Estimated

~$10 – $8,750

Fetal Care Center, PLLCNCT06728228

Characterization of Familial Myopathy and Paget Disease of Bone

The investigators are researching families with inherited inclusion body myopathy (IBM) and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also …

Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal DementiaPaget Disease of BoneFrontotemporal Dementia+1 more

Estimated

~$10 – $750

University of California, IrvineNCT01353430

Phase 2

Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function

This study seeks to evaluate the hormone responses of insulin, c-peptide, glucagon, and incretins to semaglutide, a GLP-1 receptor agonist therapy, in individu…

Stage 1 Diabetes Mellitus, Type 1

Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT07430332

Phase 4

Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)

To determine the effect of early metoprolol administration after non-traumatic subarachnoid hemorrhage (SAH).

Non-Traumatic Subarachnoid Hemorrhage

Estimated

~$10 – $7,500

Madeleine PuissantNCT06569212

Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients (Microdurva)

This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treat…

NSCLC, Stage IIILocally Advanced Lung Carcinoma

Estimated

~$10 – $1,125

Jun Zhang, MD, PhDNCT04680377

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition as…

Gastro Esophageal Reflux DiseaseBarrett Esophagus

Estimated

~$10 – $750

University of Colorado, DenverNCT06693622

Correlation Between Early Interval 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (PET/CT) and Circulating Tumor DNA (ctDNA) in Advanced Melanoma Patients Treated With Immune Checkpoint Inhibitors

The purpose of this research study is to determine if analysis of PET/CT scans and testing of blood samples in people with melanoma that has spread in their bo…

MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more

Estimated

~$10 – $750

University of Wisconsin, MadisonNCT06199713

Observational

ACTIVE MIND: An Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia

Older adults at risk for dementia show a variety of cognitive deficits, which can be ameliorated by different cognitive training (CT) exercises. The best combi…

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT04171323

Phase 2

S2210 A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 Mutations

This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mu…

Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT05806515

Observational

Enhancing Language Function in Aphasia Using Behavioral Language Intervention

Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This im…

Aphasia, AcquiredLanguage DisordersPrimary Progressive Aphasia+1 more

Estimated

~$10 – $6,250

University of ArizonaNCT05443633

Phase 2

A Randomized Phase II Trial of Hypo-fractionated Intensity-Modulated Radiation Therapy (IMRT) Utilizing 2.5 Gy/Fraction Versus (VS) Standard-Fractionated IMRT, Concurrent With Carboplatin/Paclitaxel and Followed by Consolidation Durvalumab, for Subjects With Stage 2A/B Non-Small Cell Lung Cancer

The hypothesis for this study is that hypofractionated IMRT to 62.5 Gy in 25 fractions (2.5 Gy/fraction) with concurrent carboplatin and paclitaxel, followed b…

Non Small Cell Lung Cancer Stage

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT04992780